Cooley represented Turnstone, and Latham & Watkins represented the underwriters in the IPO. Turnstone Biologics Corp. (Nasdaq: TSBX) announced the pricing of its upsized initial public...
Turnstone Biologics Corp.’s $80 Million Initial Public Offering
Turnstone Biologics’ Patent Portfolios Development
Jones Day advised Turnstone Biologics Corp. on the deal. Turnstone Biologics Corp. announced the development of patent portfolios covering its oncolytic virus programs, including its current clinical...